Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ChREBPβ is dispensable for the control of glucose homeostasis and energy balance
Emeline Recazens, … , Etienne Mouisel, Dominique Langin
Emeline Recazens, … , Etienne Mouisel, Dominique Langin
Published January 18, 2022
Citation Information: JCI Insight. 2022;7(4):e153431. https://doi.org/10.1172/jci.insight.153431.
View: Text | PDF
Research Article Metabolism

ChREBPβ is dispensable for the control of glucose homeostasis and energy balance

  • Text
  • PDF
Abstract

Impaired glucose metabolism is observed in obesity and type 2 diabetes. Glucose controls gene expression through the transcription factor ChREBP in liver and adipose tissues. Mlxipl encodes 2 isoforms: ChREBPα, the full-length form (translocation into the nucleus is under the control of glucose), and ChREBPβ, a constitutively nuclear shorter form. ChREBPβ gene expression in white adipose tissue is strongly associated with insulin sensitivity. Here, we investigated the consequences of ChREBPβ deficiency on insulin action and energy balance. ChREBPβ-deficient male and female C57BL6/J and FVB/N mice were produced using CRISPR/Cas9-mediated gene editing. Unlike global ChREBP deficiency, lack of ChREBPβ showed modest effects on gene expression in adipose tissues and the liver, with variations chiefly observed in brown adipose tissue. In mice fed chow and 2 types of high-fat diets, lack of ChREBPβ had moderate effects on body composition and insulin sensitivity. At thermoneutrality, ChREBPβ deficiency did not prevent the whitening of brown adipose tissue previously reported in total ChREBP-KO mice. These findings revealed that ChREBPβ is dispensable for metabolic adaptations to nutritional and thermic challenges.

Authors

Emeline Recazens, Geneviève Tavernier, Jérémy Dufau, Camille Bergoglio, Fadila Benhamed, Stéphanie Cassant-Sourdy, Marie-Adeline Marques, Sylvie Caspar-Bauguil, Alice Brion, Laurent Monbrun, Renaud Dentin, Clara Ferrier, Mélanie Leroux, Pierre-Damien Denechaud, Cedric Moro, Jean-Paul Concordet, Catherine Postic, Etienne Mouisel, Dominique Langin

×

Figure 4

Response of ChREBPβ-deficient mice to high-fat, high-sucrose diet.

Options: View larger image (or click on image) Download as PowerPoint
Response of ChREBPβ-deficient mice to high-fat, high-sucrose diet.
(A) B...
(A) Body weight, lean and fat mass, and organ weight in male FVB/N (n = 7–14) mice fed high-fat, high-sucrose diet. (B) Glucose (left panels) and insulin (right panels) tolerance tests (n = 8–14). (C) Blood glucose and insulin levels after 24 hours of fasting (left panels) and 18 hours of refeeding (right panels) (n = 6–14). (D) Blood lipid levels after 24 hours of fasting (left panels) and 18 hours of refeeding (right panels) (n = 6–10). Data are mean ± SEM. Statistical analysis was performed using Mann-Whitney test (A, C, and D) or 2-way ANOVA with Šídák’s post hoc test (B). *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts